Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study
Chelsea L Shover1, Titilola O Falasinnu, Rohan B Freedman
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA (CLS); Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA (TOF); Brown University, Providence, RI (RBF); Veterans Affairs Palo Alto Health Care System, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA (KH).
Objectives:
Case reports of fatal overdoses involving the novel synthetic opioid isotonitazene have prompted the U.S. Drug Enforcement Administration to consider an emergency scheduling of the drug in June 2020. We aimed to epidemiologically characterize deaths involving isotonitazene.
Methods:
We conducted a case control study using publicly available mortality records from January 1, 2020 to July 31, 2020 in Cook County, IL and Milwaukee County, WI. Cases (all deaths involving isotonitazene) and controls (all deaths involving other synthetic opioids) were compared on demographic characteristics, number of substances involved in fatal overdose, and co-involvement of other substances.
Results:
We identified 40 fatal overdoses involving isotonitazene and 981 fatal overdoses involving other synthetic opioids. Isotonitazene deaths involved a significantly greater number of substances, and were significantly more likely to involve the designer benzodiazepine flualprazolam.
Discussion:
Isotonitazene was involved in a substantial minority of synthetic opioid overdose deaths in the first 7 months of 2020. Future studies characterizing its prevalence in other markets are warranted. Emergence of highly potent novel synthetic opioids underscore the need for comprehensive health services for people with opioid use disorder.
More Related Videos
Related Concept Videos
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Abuse and Addiction: Pharmacological Phenomena
Physical Properties of Amines
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Therapeutic Drug Monitoring: Affecting Factors


